How To Pick Biotech Stocks As Sector Recovers

2017-06-13 18:30:26

A growing number of beaten-up biotech stocks have recovered from lows, about 45% of those included in the Nasdaq Biotech Index have crossed above their 200-day moving averages. Importantly, each pullback in the percentage has been smaller than the last, creating a clear one-year uptrend. Next Edge Capital Portfolio Manager Eden Rahim runs the only Canadian fund focused exclusively on biotech stocks, and tells Bloomberg TV Canada’s Amanda Lang whether it’s time to pile back into biotech stocks or exercise caution.


Industries & Politics